MiNK Therapeutics, Inc. (INKT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for MiNK Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.81x | -2.42x | -1.64x | -3.14x | -4.94x | -24.45x |
| P/B Ratio | -3.35x | -1.33x | -2.04x | -219.00x | 6.28x | -7.37x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 1.06x | 0.72x | 0.32x | 1.61x | 2.41x | 0.25x |
| Quick Ratio | 1.06x | 0.72x | 0.32x | 1.61x | 2.41x | 0.25x |
| Leverage | ||||||
| Debt/Equity | -0.36x | -0.25x | 0.00x | 0.00x | 0.00x | -0.81x |
YoY = year-over-year change. Source: FMP..